Aurora Cannabis Inc
NASDAQ:ACB
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| CA |
|
Aurora Cannabis Inc
TSX:ACB
|
292.1m CAD |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
984.9B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
592.6B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
291.5B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
235.1B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
243.5B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
306B USD |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
152.2B USD |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
123.2B USD |
Loading...
|
Market Distribution
| Min | -10 058.3% |
| 30th Percentile | 20.4% |
| Median | 33.6% |
| 70th Percentile | 50.5% |
| Max | 717.4% |
Other Profitability Ratios
Aurora Cannabis Inc
Glance View
Aurora Cannabis, Inc. engages in the production, distribution and sale of cannabis products. The firm's principal business lines are focused on the production, distribution and sale of cannabis and cannabis related products in Canada and internationally. The firm's portfolio of brands includes Aurora, Aurora Drift, San Rafael '71, Daily Special, MedReleaf, CanniMed, Whistler, Reliva and KG7 CBD. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia; and Odense, Denmark. The firm is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets. The company produces approximately 150,000 kilograms (kg) of cannabis biomass annually. Its subsidiaries include 1769474 Alberta Ltd., 2105657 Alberta Inc., Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, Aurora Nordic Cannabis A/S, and Reliva, LLC, among others.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Aurora Cannabis Inc is 1.4%, which is above its 3-year median of -2%.
Over the last 3 years, Aurora Cannabis Inc’s Gross Margin has increased from -56.9% to 1.4%. During this period, it reached a low of -56.9% on Dec 31, 2022 and a high of 4% on Jun 30, 2025.
